Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CEACAM5 by Sanofi for Metastatic Colorectal Cancer: Likelihood of Approval
CEACAM5 is under clinical development by Sanofi and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData, Phase...
Data Insights
CEACAM5 by Sanofi for Non-Small Cell Lung Cancer: Likelihood of Approval
CEACAM5 is under clinical development by Sanofi and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...